Chronic Fatigue Syndrome Trial, Recruiting NCT03675087 Sponsor: Escuela Universitaria de Fisioterapia de la Once Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT03675087
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with CFS/ME (Chronic Fatigue Syndrome/Myalgic Encephalomyelitis) by a specialist in internal medicine with experience in this condition, using the recommended 2015 diagnostic guidelines.
  • You are willing and able to sign a consent form agreeing to take part in the study.

Who may not be able to join:

  • You have been diagnosed with a primary psychiatric disorder (such as a major mental health condition), a somatoform disorder (a condition where physical symptoms are linked to psychological causes), or a substance abuse problem.
  • You have a heart condition such as decompensated heart failure, unstable angina, a very recent heart attack (within the last 3 days), poorly controlled irregular heartbeat, or severe heart valve narrowing.
  • You have an infection or inflammation of the heart (endocarditis, myocarditis, or acute pericarditis).
  • You have fluid in the lungs (acute pulmonary edema) or significant high blood pressure in the lungs (pulmonary arterial hypertension).
  • You have a suspected or known dangerous widening or tearing of the main artery (aortic aneurysm or dissection).
  • Your blood oxygen level at rest is below 85%.
  • You have acute (sudden) kidney failure.
  • You have an untreated overactive thyroid (thyrotoxicosis).
  • You have an active infection.
  • You have very high blood pressure (above 200/120 mmHg) that is not under control.
  • You have a specific type of thickened heart muscle condition (hypertrophic obstructive cardiomyopathy) or a significant electrical conduction problem in your heart (high-grade atrioventricular block).
  • You have episodes of fainting (syncope).
  • You are in an advanced or high-risk pregnancy.
  • You have a significant imbalance of minerals/electrolytes in your blood (confirm with trial site).
  • You have severe anemia (very low red blood cell levels).
  • You have a blood clot in the lungs (pulmonary embolism) or an inflamed clot in a vein (acute thrombophlebitis).
  • You have a bone, joint, or neurological condition that prevents you from walking or cycling.
  • You are unable to understand and follow the instructions given during the tests.
  • You have also been diagnosed with Multiple Chemical Sensitivity Syndrome.
  • You have already completed a specific type of peak exercise breathing test (incremental CPET) within the last 3 years.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ana B Varas-de-la-Fuente, Chair, Escuela Universitaria de Fisioterapia de la Once

Phone: 915894500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Escuela Universitaria de Fisioterapia de la Once
Registry
ClinicalTrials.gov
Start date
27 February 2019
Est. completion
1 July 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Mean Value of the Peak VO2 in both Exercise Tests (6MWT and Peak CPET) in Milillitres/ Minute.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov